SEBI Issues Advisory Letter to Sheel Biotech for Delayed LODR Disclosure
Sheel Biotech Ltd 路 Others (Uncategorized) 路 25 Sept 2026, 8:46 pm
SEBI Issues Advisory Letter to Sheel Biotech for Delayed LODR Disclosure Sheel Biotech Limited received an advisory letter dated 3rd Sep'26 from SEBI regarding non-compliance with Regulation 32(6) of SEBI LODR Regulations. The advisory pertains to a delayed disclosure of the Monitoring Agency report issued by CARE Ratings Limited. The letter is purely advisory, imposing no financial penalties, fines, or operational restrictions on the company. Sheel Biotech noted the matter on 25th Sep'26 and confirmed it will ensure strict future compliance to prevent repeat lapses.
Original exchange filing (PDF)
More announcements from Sheel Biotech Ltd
- Sheel Biotech Limited has informed the Exchange regarding 'Investor Presentation'. 路 17 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Monitoring Agency Report for the Half year ended on 30th September, 2026. 路 13 Nov 2026
- SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 13 Nov 2026
- Sheel Biotech Limited has informed the Exchange about receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production. 路 30 Oct 2026
- Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026. 路 14 Oct 2026
